Phase 1 Stroke Trial, Recruiting NCT06938243 Sponsor: Qilu Hospital of Shandong University Condition: Stroke
Back to Stroke

Phase 1 Stroke Trial, Recruiting

NCT06938243
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had a first-time stroke on one side of the brain, caused by a blocked blood vessel in a specific brain region (the middle cerebral artery area), where the stroke did not affect certain deeper brain structures (the diencephalon and basal ganglia), and the stroke occurred between 3 and 36 months before the surgery date.
  • People who still have moderate to severe weakness in one arm and hand after their stroke, as measured by a specific arm movement scoring tool (confirm with trial site for exact score details).
  • People who still have at least some small amount of movement remaining in their elbow or fingers on the affected side, as measured by the same scoring tool.

Who may not be able to join:

  • People whose affected arm or hand muscles are extremely stiff or rigid (a condition called severe spasticity or contracture), rated at the highest level on a standard medical stiffness scale.
  • People who have significant difficulties with memory, thinking, or understanding, as determined by a standard cognitive assessment test scoring below a certain threshold.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 13969007232

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
Qilu Hospital of Shandong University
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
1 May 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

FM-UE scores between early and late VNS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov